BROWN AND BURK PHILIPPINES INC — Glimepiride Importer Profile
Pharmaceutical Importer · #12 buyer for Glimepiride · $516.3K import value · 20 shipments · PHILIPPINES · DGFT Verified
BROWN AND BURK PHILIPPINES INC is the #12 importer of Glimepiride from India with $516.3K in import value and 20 verified shipments. BROWN AND BURK PHILIPPINES INC holds a 0.6% market share in Glimepiride imports based in PHILIPPINES. The company sources from 1 verified supplier across 20 formulations shipped to 2 countries. Overall, BROWN AND BURK PHILIPPINES INC imports 2 pharmaceutical products worth $887.9K across 1 therapeutic categories.
BROWN AND BURK PHILIPPINES INC — Glimepiride Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Glimepiride to BROWN AND BURK PHILIPPINES INC?
Verified from 20 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MICRO LABS LIMITED | $516.3K | 20 | 100.0% |
BROWN AND BURK PHILIPPINES INC sources Glimepiride from 1 verified Indian supplier based on 20 customs records. The primary supplier is MICRO LABS LIMITED accounting for 100.0% of imports.
How Does BROWN AND BURK PHILIPPINES INC Compare to Nearest Glimepiride Importers?
Buyers ranked immediately above and below #12 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | I.E. MEDICA INC. | PHILIPPINES | $574.6K | 15 | $38.3K |
| 11 | MAXXCARE COMPANY LIMITED | VIETNAM | $476.0K | 13 | $36.6K |
| 12 | BROWN AND BURK PHILIPPINES INC ★ | PHILIPPINES | $460.0K | 13 | $35.4K |
| 14 | ZENTIVA SA ROMANIA | ROMANIA | $443.2K | 15 | $29.5K |
| 13 | MAXXCARE COMPANY LIMITED. | VIETNAM | $400.0K | 8 | $50.0K |
BROWN AND BURK PHILIPPINES INC ranks #12 among 535 Glimepiride importers from India. Average shipment value of $35.4K compared to the market average of $17.0K. The closest competitors by value are I.E. MEDICA INC. and MAXXCARE COMPANY LIMITED.
Where Does BROWN AND BURK PHILIPPINES INC Import Glimepiride To?
Destination countries from 20 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $468.8K | 15 | 90.8% |
| UNITED KINGDOM | $47.5K | 5 | 9.2% |
BROWN AND BURK PHILIPPINES INC imports Glimepiride to 2 countries. The primary destination is PHILIPPINES receiving 90.8% of shipments worth $468.8K.
What Glimepiride Formulations Does BROWN AND BURK PHILIPPINES INC Import?
| Formulation | Value | Shipments |
|---|---|---|
| TRIPRIDE 2 ( (Glimepiride + Pioglitazone | $50.0K | 1 |
| TRIPRIDE 2 (GLIMEPIRIDE 2MG, PIOGLITAZONE HCL 15MG, METFORMIN HCL 500MG TABLETS)(1X10s) - TAX INVOICE NO: 705202586 DT: | $50.0K | 1 |
| TRIPRIDE 2 (GLIMEPIRIDE 2MG, PIOGLITAZONE HCL 15MG, METFORMIN HCL 500MG TABLETS)(3X10?S) (QTY-26003.000) TAX INV NO: 70 | $50.0K | 1 |
| TRIPRIDE 2 Glimepiride 2mg + Pioglitazone HCL 15mg + Metformin HCL 500mg TABLETS 1X10S QTY - 51681.000 | $43.7K | 1 |
| TRIPRIDE 2 GLIMEPIRIDE 2MG + PIOGLITAZONE HCL 15MG + METFORMIN HCL 500MG TABLETS 1X10'S QTY-38788 TAX DOCUMENT NO: 705202 | $35.6K | 1 |
| TRIPRIDE 2 ( (GLIMEPIRIDE 2MG + PIOGLITAZONE HCL 15MG + METFORMIN HCL 500MG TABLETS ) ( 1X10S ) ( QTY- 41655 ) | $35.3K | 1 |
| TRIPRIDE 2 ( (GLIMEPIRIDE 2MG + PIOGLITAZONE HCL 15MG + METFORMIN HCL 500MG TABLETS ) ( 1X10S ) ( QTY- 39265.000 ) | $33.3K | 1 |
| TRIPRIDE 2 GLIMEPIRIDE 2MG + PIOGLITAZO | $32.1K | 1 |
| TRIPRIDE 2 ( (GLIMEPIRIDE 2MG + PIOGLITAZONE HCL 15MG + METFORMIN HCL 500MG TABLETS ) ( 1X10S ) ( QTY- 35190.000 ) | $29.9K | 1 |
| TRIPRIDE 2 Glimepiride 2mg + Pioglitazone HCL 15mg +Metformin HCL 500mg Tablets 3x10s | $29.2K | 1 |
BROWN AND BURK PHILIPPINES INC imports 20 distinct Glimepiride formulations from India. The top formulation is TRIPRIDE 2 ( (Glimepiride + Pioglitazone with 1 shipments worth $50.0K.
Who Are the Top Buyers of Glimepiride from India and How Much Does BROWN AND BURK PHILIPPINES INC Import?
India exported $9.1M worth of Glimepiride through 3,159 shipments from 242 suppliers to 94 countries, serving 535 buyers globally. BROWN AND BURK PHILIPPINES INC imports $516.3K of this total, accounting for 0.6% of India's Glimepiride exports with 20 shipments from PHILIPPINES. This is verified from 20 customs shipment records covering 20 distinct formulations.
What Is the Average Order Value for BROWN AND BURK PHILIPPINES INC's Glimepiride Imports?
BROWN AND BURK PHILIPPINES INC's average Glimepiride order value is $25.8K per consignment, based on 20 shipments totaling $516.3K. BROWN AND BURK PHILIPPINES INC is based in PHILIPPINES and ranks #12 among all Glimepiride importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Glimepiride to BROWN AND BURK PHILIPPINES INC?
BROWN AND BURK PHILIPPINES INC sources Glimepiride from 1 verified Indian supplier: MICRO LABS LIMITED ($516.3K, 100.0%). This is based on 20 customs records.
How Does BROWN AND BURK PHILIPPINES INC Compare to Other Glimepiride Importers?
BROWN AND BURK PHILIPPINES INC ranks #12 among 535 Glimepiride importers from India with a 0.6% market share. The top 3 importers are EVERSANA LIFE SCIENCE SERVICES, LLC ($1.3M), EVERSANA LIFE SCIENCE SERVICES LLC ($905.2K), APL SWIFT SERVICES (MALTA) LTD., ($780.5K). BROWN AND BURK PHILIPPINES INC processed 20 shipments from PHILIPPINES.
What Other Diabetes & Endocrine Products Does BROWN AND BURK PHILIPPINES INC Import?
BROWN AND BURK PHILIPPINES INC also imports these diabetes & endocrine products. Each links to the detailed product page.
About BROWN AND BURK PHILIPPINES INC
BROWN AND BURK PHILIPPINES INC imports 2 products worth $887.9K. Beyond Glimepiride, top products include Pioglitazone. View the complete BROWN AND BURK PHILIPPINES INC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Glimepiride — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Glimepiride shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: BROWN AND BURK PHILIPPINES INC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as BROWN AND BURK PHILIPPINES INC's capped import value divided by total capped export value for Glimepiride across all Indian exporters.
- 5.Verified Records: This page is backed by 20 individual customs records matching BROWN AND BURK PHILIPPINES INC importing Glimepiride, covering 20 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 94+ countries, 535+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Glimepiride Import Data for BROWN AND BURK PHILIPPINES INC
Access order-level details, pricing data, supplier connections, and competitive analysis for BROWN AND BURK PHILIPPINES INC's Glimepiride imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
BROWN AND BURK PHILIPPINES INC
Full Company Profile →
2 products · $887.9K total trade · 1 categories
BROWN AND BURK PHILIPPINES INC × Glimepiride
Verified from customs records
Company Overview
Top Products by BROWN AND BURK PHILIPPINES INC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for BROWN AND BURK PHILIPPINES INC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Glimepiride. For current order-level data, contact TransData Nexus.